US Stock MarketDetailed Quotes

West Pharmaceutical Services (WST)

Watchlist
  • 279.410
  • +4.430+1.61%
Close Jan 15 16:00 ET
20.10BMarket Cap41.39P/E (TTM)

West Pharmaceutical Services (WST) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
Total revenue
7.73%804.6M
9.17%766.5M
0.37%698M
-1.92%2.89B
2.30%748.8M
-0.07%746.9M
-6.86%702.1M
-2.96%695.4M
2.18%2.95B
3.29%732M
Operating revenue
7.73%804.6M
9.17%766.5M
0.37%698M
-1.92%2.89B
2.30%748.8M
-0.07%746.9M
-6.86%702.1M
-2.96%695.4M
2.18%2.95B
3.29%732M
Cost of revenue
5.83%510.3M
4.34%492.6M
0.19%466.1M
4.07%1.89B
4.72%475.2M
5.03%482.2M
2.10%472.1M
4.47%465.2M
3.99%1.82B
1.61%453.8M
Gross profit
11.18%294.3M
19.09%273.9M
0.74%231.9M
-11.57%998.5M
-1.65%273.6M
-8.19%264.7M
-21.07%230M
-15.15%230.2M
-0.62%1.13B
6.14%278.2M
Operating expense
21.01%119.8M
14.43%115M
0.00%104.3M
-3.37%407.6M
-4.24%103.8M
-6.07%99M
-4.19%100.5M
1.16%104.3M
12.36%421.8M
6.69%108.4M
Selling and administrative expenses
22.99%102.7M
15.54%95.9M
1.50%88M
-4.22%338.5M
-5.22%85.3M
-6.18%83.5M
-6.11%83M
0.81%86.7M
11.52%353.4M
5.02%90M
Research and development costs
10.32%17.1M
9.14%19.1M
-7.39%16.3M
1.02%69.1M
0.54%18.5M
-5.49%15.5M
6.06%17.5M
2.92%17.6M
16.92%68.4M
15.72%18.4M
Operating profit
5.31%174.5M
22.70%158.9M
1.35%127.6M
-16.47%590.9M
0.00%169.8M
-9.40%165.7M
-30.56%129.5M
-25.15%125.9M
-7.02%707.4M
5.79%169.8M
Net non-operating interest income expense
15.38%4.5M
40.00%3.5M
-19.57%3.7M
-12.63%16.6M
-31.71%5.6M
-33.90%3.9M
8.70%2.5M
76.92%4.6M
778.57%19M
583.33%8.2M
Non-operating interest income
2.17%4.7M
-10.00%3.6M
-33.87%4.1M
-30.00%19.6M
-48.94%4.8M
-47.73%4.6M
-20.00%4M
29.17%6.2M
449.02%28M
224.14%9.4M
Non-operating interest expense
-71.43%200K
-93.33%100K
-75.00%400K
-66.67%3M
-166.67%-800K
-75.86%700K
-44.44%1.5M
-27.27%1.6M
13.92%9M
-29.41%1.2M
Other net income (expense)
-39.22%-7.1M
-63.64%-5.4M
-570.97%-20.8M
22.54%-22M
-7.14%-10.5M
-183.33%-5.1M
15.38%-3.3M
75.97%-3.1M
63.64%-28.4M
70.30%-9.8M
Gain on sale of security
34.15%-2.7M
15.00%-1.7M
0.00%-1.2M
-8.51%-10.2M
54.69%-2.9M
-127.78%-4.1M
-566.67%-2M
-33.33%-1.2M
-329.27%-9.4M
-204.76%-6.4M
Special income (charges)
-1,400.00%-3.9M
-146.15%-3.2M
-1,093.75%-19.1M
52.17%-9.9M
-386.67%-7.3M
107.14%300K
61.76%-1.3M
86.21%-1.6M
37.27%-20.7M
95.07%-1.5M
-Less:Restructuring and merger&acquisition
376.92%3.6M
140.00%2.4M
1,780.00%18.8M
620.00%2.6M
258.33%1.9M
-285.71%-1.3M
433.33%1M
233.33%1M
-101.87%-500K
-104.65%-1.2M
-Less:Impairment of capital assets
----
----
-50.00%300K
----
----
----
----
-68.42%600K
----
----
-Write off
-70.00%300K
166.67%800K
----
-23.96%7.3M
100.00%5.4M
-71.43%1M
-80.00%300K
----
54.84%9.6M
-41.30%2.7M
-Gain on sale of property,plant,equipment
----
----
----
--0
--0
--0
--0
----
---11.6M
--0
Other non- operating income (expenses)
61.54%-500K
---500K
-66.67%-500K
-211.76%-1.9M
84.21%-300K
-130.95%-1.3M
----
25.00%-300K
103.46%1.7M
-280.00%-1.9M
Income before tax
4.50%171.9M
21.99%157M
-13.27%110.5M
-16.12%585.5M
-1.96%164.9M
-12.03%164.5M
-30.39%128.7M
-19.32%127.4M
2.66%698M
30.69%168.2M
Income tax
4.94%34M
37.90%30.2M
46.95%24.1M
-12.10%107.5M
6.67%36.8M
10.20%32.4M
-37.07%21.9M
-30.51%16.4M
6.63%122.3M
19.38%34.5M
Earnings from equity interest net of tax
-46.15%2.1M
11.11%5M
-20.93%3.4M
-16.95%14.7M
-39.39%2M
5.41%3.9M
-10.00%4.5M
-24.56%4.3M
-14.49%17.7M
3.13%3.3M
Net income
2.94%140M
18.42%131.8M
-22.12%89.8M
-16.97%492.7M
-5.04%130.1M
-15.69%136M
-28.24%111.3M
-17.64%115.3M
1.28%593.4M
33.01%137M
Net income continuous Operations
2.94%140M
18.42%131.8M
-22.12%89.8M
-16.97%492.7M
-5.04%130.1M
-15.69%136M
-28.24%111.3M
-17.64%115.3M
1.28%593.4M
33.01%137M
Minority interest income
Net income attributable to the parent company
2.94%140M
18.42%131.8M
-22.12%89.8M
-16.97%492.7M
-5.04%130.1M
-15.69%136M
-28.24%111.3M
-17.64%115.3M
1.28%593.4M
33.01%137M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
2.94%140M
18.42%131.8M
-22.12%89.8M
-16.97%492.7M
-5.04%130.1M
-15.69%136M
-28.24%111.3M
-17.64%115.3M
1.28%593.4M
33.01%137M
Basic earnings per share
3.74%1.94
19.74%1.82
-21.02%1.24
-15.41%6.75
-3.24%1.79
-13.82%1.87
-26.92%1.52
-16.49%1.57
1.40%7.98
34.06%1.85
Diluted earnings per share
3.78%1.92
20.53%1.82
-20.65%1.23
-15.10%6.69
-2.73%1.78
-13.55%1.85
-26.70%1.51
-16.22%1.55
1.94%7.88
34.56%1.83
Dividend per share
5.00%0.21
5.00%0.21
5.00%0.21
5.19%0.81
5.00%0.21
5.26%0.2
5.26%0.2
5.26%0.2
5.48%0.77
5.26%0.2
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
--
--
(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023
Total revenue 7.73%804.6M9.17%766.5M0.37%698M-1.92%2.89B2.30%748.8M-0.07%746.9M-6.86%702.1M-2.96%695.4M2.18%2.95B3.29%732M
Operating revenue 7.73%804.6M9.17%766.5M0.37%698M-1.92%2.89B2.30%748.8M-0.07%746.9M-6.86%702.1M-2.96%695.4M2.18%2.95B3.29%732M
Cost of revenue 5.83%510.3M4.34%492.6M0.19%466.1M4.07%1.89B4.72%475.2M5.03%482.2M2.10%472.1M4.47%465.2M3.99%1.82B1.61%453.8M
Gross profit 11.18%294.3M19.09%273.9M0.74%231.9M-11.57%998.5M-1.65%273.6M-8.19%264.7M-21.07%230M-15.15%230.2M-0.62%1.13B6.14%278.2M
Operating expense 21.01%119.8M14.43%115M0.00%104.3M-3.37%407.6M-4.24%103.8M-6.07%99M-4.19%100.5M1.16%104.3M12.36%421.8M6.69%108.4M
Selling and administrative expenses 22.99%102.7M15.54%95.9M1.50%88M-4.22%338.5M-5.22%85.3M-6.18%83.5M-6.11%83M0.81%86.7M11.52%353.4M5.02%90M
Research and development costs 10.32%17.1M9.14%19.1M-7.39%16.3M1.02%69.1M0.54%18.5M-5.49%15.5M6.06%17.5M2.92%17.6M16.92%68.4M15.72%18.4M
Operating profit 5.31%174.5M22.70%158.9M1.35%127.6M-16.47%590.9M0.00%169.8M-9.40%165.7M-30.56%129.5M-25.15%125.9M-7.02%707.4M5.79%169.8M
Net non-operating interest income expense 15.38%4.5M40.00%3.5M-19.57%3.7M-12.63%16.6M-31.71%5.6M-33.90%3.9M8.70%2.5M76.92%4.6M778.57%19M583.33%8.2M
Non-operating interest income 2.17%4.7M-10.00%3.6M-33.87%4.1M-30.00%19.6M-48.94%4.8M-47.73%4.6M-20.00%4M29.17%6.2M449.02%28M224.14%9.4M
Non-operating interest expense -71.43%200K-93.33%100K-75.00%400K-66.67%3M-166.67%-800K-75.86%700K-44.44%1.5M-27.27%1.6M13.92%9M-29.41%1.2M
Other net income (expense) -39.22%-7.1M-63.64%-5.4M-570.97%-20.8M22.54%-22M-7.14%-10.5M-183.33%-5.1M15.38%-3.3M75.97%-3.1M63.64%-28.4M70.30%-9.8M
Gain on sale of security 34.15%-2.7M15.00%-1.7M0.00%-1.2M-8.51%-10.2M54.69%-2.9M-127.78%-4.1M-566.67%-2M-33.33%-1.2M-329.27%-9.4M-204.76%-6.4M
Special income (charges) -1,400.00%-3.9M-146.15%-3.2M-1,093.75%-19.1M52.17%-9.9M-386.67%-7.3M107.14%300K61.76%-1.3M86.21%-1.6M37.27%-20.7M95.07%-1.5M
-Less:Restructuring and merger&acquisition 376.92%3.6M140.00%2.4M1,780.00%18.8M620.00%2.6M258.33%1.9M-285.71%-1.3M433.33%1M233.33%1M-101.87%-500K-104.65%-1.2M
-Less:Impairment of capital assets ---------50.00%300K-----------------68.42%600K--------
-Write off -70.00%300K166.67%800K-----23.96%7.3M100.00%5.4M-71.43%1M-80.00%300K----54.84%9.6M-41.30%2.7M
-Gain on sale of property,plant,equipment --------------0--0--0--0-------11.6M--0
Other non- operating income (expenses) 61.54%-500K---500K-66.67%-500K-211.76%-1.9M84.21%-300K-130.95%-1.3M----25.00%-300K103.46%1.7M-280.00%-1.9M
Income before tax 4.50%171.9M21.99%157M-13.27%110.5M-16.12%585.5M-1.96%164.9M-12.03%164.5M-30.39%128.7M-19.32%127.4M2.66%698M30.69%168.2M
Income tax 4.94%34M37.90%30.2M46.95%24.1M-12.10%107.5M6.67%36.8M10.20%32.4M-37.07%21.9M-30.51%16.4M6.63%122.3M19.38%34.5M
Earnings from equity interest net of tax -46.15%2.1M11.11%5M-20.93%3.4M-16.95%14.7M-39.39%2M5.41%3.9M-10.00%4.5M-24.56%4.3M-14.49%17.7M3.13%3.3M
Net income 2.94%140M18.42%131.8M-22.12%89.8M-16.97%492.7M-5.04%130.1M-15.69%136M-28.24%111.3M-17.64%115.3M1.28%593.4M33.01%137M
Net income continuous Operations 2.94%140M18.42%131.8M-22.12%89.8M-16.97%492.7M-5.04%130.1M-15.69%136M-28.24%111.3M-17.64%115.3M1.28%593.4M33.01%137M
Minority interest income
Net income attributable to the parent company 2.94%140M18.42%131.8M-22.12%89.8M-16.97%492.7M-5.04%130.1M-15.69%136M-28.24%111.3M-17.64%115.3M1.28%593.4M33.01%137M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 2.94%140M18.42%131.8M-22.12%89.8M-16.97%492.7M-5.04%130.1M-15.69%136M-28.24%111.3M-17.64%115.3M1.28%593.4M33.01%137M
Basic earnings per share 3.74%1.9419.74%1.82-21.02%1.24-15.41%6.75-3.24%1.79-13.82%1.87-26.92%1.52-16.49%1.571.40%7.9834.06%1.85
Diluted earnings per share 3.78%1.9220.53%1.82-20.65%1.23-15.10%6.69-2.73%1.78-13.55%1.85-26.70%1.51-16.22%1.551.94%7.8834.56%1.83
Dividend per share 5.00%0.215.00%0.215.00%0.215.19%0.815.00%0.215.26%0.25.26%0.25.26%0.25.48%0.775.26%0.2
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion------------
Market Insights
Nancy Pelosi Portfolio
China Concept Stocks
View More
The Fed Delivers Third Consecutive Rate Cut as Expected! How to Position for Year-End U.S. Equity Ma
On December 19, the Bank of Japan raised interest rates by 25 basis points as expected, in line with market forecasts. On the evening of Dec Show More